Bajaj Finserv Healthcare Fund - Growth - Regular Plan

Other Plans and Options
  • (-0.59%)Nav, as on 12-02-2026

  • Previous Nav

  • Net Change on 12-02-2026

  • PersonalFN Rating

  • Assets (Cr.)

  • Expense Ratio

Fund Overview Growth | Regular Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

The objective of the Scheme is to generate long term capital appreciation by predominantly investing in equity and equity related securities of pharma, healthcare and allied companies.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
BSE Health Care - TRI N/A N/A N/A N/A N/A N/A
NIFTY 50 - TRI N/A N/A N/A N/A N/A N/A

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Cumulative Option Jul 13, 2018 6.32 26.74 16.57 1.86 6,658.41
Tata India Pharma & Healthcare Fund-Regular Plan-Growth Dec 28, 2015 4.61 22.09 14.47 2.14 1,239.57
UTI Healthcare Fund - Regular Plan - Growth Option Aug 01, 2005 7.46 24.38 14.75 2.28 1,055.01

Fund Holdings as on 31-January-2026

  • Divi's Laboratories Limited

  • Sun Pharmaceutical Industries Limited

  • Apollo Hospitals Enterprise Limited

  • Aurobindo Pharma Limited

  • Piramal Pharma Limited

  • Emcure Pharmaceuticals Limited

  • Cipla Limited

  • Neuland Laboratories Limited

  • Fortis Healthcare Limited

  • Rubicon Research Limited

  • Net Receivables / (Payables)

  • Max Healthcare Institute Limited February 2026 Future

  • Glenmark Pharmaceuticals Limited

  • Lupin Limited

  • IPCA Laboratories Limited

  • Biocon Limited

  • Zydus Wellness Limited

  • Eternal Limited

  • Pfizer Limited

  • Eternal Limited February 2026 Future

  • Vijaya Diagnostic Centre Limited

  • Sanofi Consumer Healthcare India Limited

  • Godrej Consumer Products Limited

  • GlaxoSmithKline Pharmaceuticals Limited

  • Bajaj Finserv Money Market Fund-Direct Plan-Growth

  • Dr. Lal Path Labs Limited

  • Abbott India Limited

  • Shaily Engineering Plastics Limited

  • MedPlus Health Services Limited

  • Torrent Pharmaceuticals Limited

  • Medi Assist Healthcare Services Limited

  • Hindustan Unilever Limited

  • Jubilant Pharmova Limited

  • Tata Consumer Products Limited

  • Rainbow Childrens Medicare Limited

  • Max Healthcare Institute Limited

  • Emami Limited

  • Alembic Pharmaceuticals Limited

  • AstraZeneca Pharma India Limited

  • Clearing Corporation of India Ltd

  • Kwality Walls (India) Limited **

  • Sun Pharmaceutical Industries Limited February 2026 Future

View More

  • Pharmaceuticals & Drugs

  • Hospital & Healthcare Services

  • Household & Personal Products

  • Miscellaneous

  • Consumer Food

  • e-Commerce

  • Plastic Products

  • Retailing

  • Business Support

  • Tea/Coffee

  • Unspecified

View More

Fund Manager

  • Cash

  • Derivatives

  • Equity

  • MFU

View More

About Bajaj Finserv Healthcare Fund

Scheme Analysis

Bajaj Finserv Healthcare Fund is a Equity - Sectoral Fund - Pharma & Health Care fund and belongs to Bajaj Finserv Mutual Fund. It was launched on 27-Dec-2024 and currently has an AUM of ₹307.34 crore. Bajaj Finserv Healthcare Fund is benchmarked against BSE Health Care - TRI as primary index and NIFTY 50 - TRI as secondary index.

The NAV of Bajaj Finserv Healthcare Fund ended down ₹-0.06(-0.59%)yesterday to ₹9.463.

Among its top 3 holdings the fund has exposure to Divi's Laboratories Limited, and

The Bajaj Finserv Healthcare Fund is managed by Nimesh Chandan and Siddharth Chaudhary.

Fund House Contact

S. No. 208/1B, Lohagaon Viman Nagar Pune - 411014

1800-309-3900
service@bajajamc.com
020-67672550